2026-03-20 – Press Releases – www.prnewswire.com
SHANGHAI, March 20, 2026 /PRNewswire/ — D3 Bio Inc, a global clinical-stage biotechnology company focused on developing transformative oncology therapeutics, is pleased to announce that five abstracts have been accepted for presentation at the upcoming American Association for Cancer…
